MedAlliance receives third FDA breakthrough device designation for its sirolimus DEB in the treatment...

MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) breakthrough device designation status for a...

German claims data report higher long-term and amputation-free survival in CLTI patients treated with...

There is no sign of increased all-cause mortality following the use of paclitaxel-coated devices for the treatment of symptomatic peripheral arterial occlusive disease, a...

FDA issues guidance on PTA balloon and specialty catheter 510(k) submissions

The US Food and Drug Administration (FDA) has released draft guidance detailing the information device-makers should include in 510(k) submissions of catheter-based devices intended...
natural

Alucent Biomedical announces FDA approval to proceed with natural vascular scaffolding clinical trial

Alucent Biomedical has received US Food and Drug Administration (FDA) approval to proceed with a phase 1 clinical trial to evaluate the safety and...

Ian Loftus

Alan Lumsden

Kim Hodgson